// App-Quantinova.ai

19 : Management and Outcomes of Major Bleeding On Dabigatran or Warfarin

Researchers

Presenter

  • Hun-Gyu Hwang

Principal Investigators

  • Martina Brueckmann

  • Co. KG

  • Stuart Connolly

  • John Eikelboom

  • Michael Ezekowitz

  • Lars Wallentin

  • Salim Yusuf

  • Sam Schulman

Medical Centers

  • Rheumatology Unit, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden

  • Ingelheim, Germany

  • Uppsala Clinical Research Center, Uppsala, Sweden

  • Department of Medicine, McMaster University, Hamilton, ON, Canada

Locations

  • Canada

  • Germany

  • Sweden

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Arrhythmia

Biomarkers

  • Creatinine

Drug/Treatment

  • Prothrombin complex

  • rFVIIa

  • Pradax

  • Warfarin

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved